Insider trade

Hims & Hers Health (HIMS): CEO sold ~$429K

Andrew Dudum, CEO at Hims & Hers Health, sold ~$429K of Hims & Hers Health shares.

~$429K
Approx. value · 14K sh @ $30.08
28K
Holds after · shares reported
Traded
Jan 22, 2025
Filed
Jan 23, 2025

What stands out in this filing

  • The sale was 33.8% of the shares this insider held before it; the filing reports 27,918 shares afterwards.
  • 14,269 shares at an average of $30.08 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 25, 2024Insider · 2 peopleInsiders: 5 sales (~$3.5M)
  2. Nov 26, 2024InsiderOfficer sold ~$70K of HIMS shares in the open market
  3. Dec 2, 2024Insider · 2 peopleInsiders: 2 sales (~$1.2M)
  4. Dec 10, 2024Insider · 2 peopleInsiders: 4 sales (~$2.9M)
  5. Dec 16, 2024Insider · 2 peopleInsiders: 7 sales (~$3.7M)
  6. Dec 17, 2024Insider · 3 peopleInsiders: 4 sales (~$3.7M)
  7. Dec 19, 2024InsiderOfficer sold ~$195K of HIMS shares in the open market
  8. Dec 20, 2024Insider · 1 personInsiders: 4 sales (~$489K)
  9. Dec 24, 2024InsiderOfficer sold ~$484K of HIMS shares in the open market
  10. Dec 26, 2024InsiderCFO sold ~$126K of HIMS shares in the open market
  11. Jan 2, 2025Insider · 2 peopleInsiders: 4 sales (~$336K)
  12. Jan 6, 2025Insider · 1 personInsiders: 2 sales (~$7.5M)
  13. Jan 10, 2025InsiderOfficer sold ~$175K of HIMS shares in the open market
  14. Jan 13, 2025Insider · 1 personInsiders: 3 sales (~$283K)
  15. Jan 16, 2025Insider · 1 personInsiders: 6 sales (~$2.3M)
  16. Jan 21, 2025Insider · 4 peopleInsiders: 10 sales (~$3.6M)
  17. Jan 22, 2025 · this disclosureInsiderCEO sold ~$429K of HIMS shares in the open market

What came next

  1. Jan 23, 2025InsiderCEO sold ~$815K of HIMS shares in the open market
  2. Jan 24, 2025InsiderOfficer sold ~$536K of HIMS shares in the open market
  3. Jan 31, 2025InsiderCEO sold ~$3.52M of HIMS shares in the open market
  4. Feb 3, 2025Insider · 2 peopleInsiders: 2 sales (~$219K)
  5. Feb 4, 2025Insider · 1 personInsiders: 4 sales (~$451K)
  6. Feb 10, 2025Insider · 2 peopleInsiders: 4 sales (~$812K)
  7. Feb 12, 2025Insider · 1 personInsiders: 4 sales (~$3.0M)
  8. Feb 18, 2025Insider · 2 peopleInsiders: 5 sales (~$7.1M)
  9. Feb 19, 2025InsiderOfficer sold ~$444K of HIMS shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

Other recent filings by Andrew Dudum, Chief Executive Officer

The full history of Andrew Dudum, Chief Executive Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Hims & Hers Health (HIMS) insider traded, and how much?

Andrew Dudum, CEO at Hims & Hers Health, sold ~$429K of Hims & Hers Health shares. 14K shares at $30.08.

When did it happen, and when was it made public?

Traded: Jan 22, 2025. Filed: Jan 23, 2025. That is 1 day between the two dates.

What stands out in this filing?

The sale was 33.8% of the shares this insider held before it; the filing reports 27,918 shares afterwards. 14,269 shares at an average of $30.08 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Hims & Hers Health recently?

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.

Does this mean HIMS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data